Novartis new two-year data with Certican® shows positive outcomes at 24 ... Insciences Organisation Enrollment into the tacrolimus withdrawal arm was prematurely halted due to a higher incidence of acute rejection episodes and adverse events leading to treatment discontinuation, clustered around the time of tacrolimus elimination at four months post ... |
